Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, July 17, 2018

Public edition | newswise.com

Newswise Cancer Research Wire for 17-Jul-2018
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Overcoming a Major Barrier to Developing Liquid Biopsies

An international consortium of labs tested nine different methods for RNA sequencing to understand and standardize the best methods for sequencing small RNAs. The goal was to create a process that could be reproduced from one lab to the next to furth...

– Michigan Medicine - University of Michigan

Nature Biotechnology; HL126499; HL126496; HL126493; HL126494; HL126495; HL126497; TR000891; P30CA046592

Embargo expired on 16-Jul-2018 at 11:00 ET


Researchers Shrink Tumors in Mice by Manipulating Brain's Reward System

Researchers at the Technion-Israel Institute of Technology have successfully shrunk cancerous tumors in mice by manipulating the brain’s reward system. The intervention caused the nervous system to stimulate the immune system.

– American Technion Society

Nature Communications, Jul 13-2016


By Sending Tests in the Mail, Researchers Boost Colorectal Cancer Screening

Researchers with UNC Lineberger’s Carolina Cancer Screening Initiative, in collaboration with the Mecklenburg County Health Department in Charlotte, examined the impact of mailing tests to more than 2,100 people insured by Medicaid who were not up-...

– University of North Carolina Health Care System


Tackling Cancer at Ground Zero with Designer Molecules

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers.

– University of Adelaide

Chemistry, A European Journal


Testosterone Research Brings New Hope for Cancer Patients

Dr. Melinda Sheffield-Moore, professor and head of the Department of Health and Kinesiology, along with researchers at University of Texas Medical Branch, recently published research showing that the hormone testosterone is effective at combatting ca...

– Texas A&M University

Journal of Cachexia, Sarcopenia and Muscle 2018;9: 482–496; RO1CA127971


Is Surgery the Best Option for Penetrating Kidney Trauma?

SLU surgeon Sameer A. Siddiqui, M.D., and his research team examined patient records to study the best approach for renal trauma injuries.

– Saint Louis University Medical Center


Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers

A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international research team report...

– University of Texas M. D. Anderson Cancer Center

JAMA Oncology

Embargo expired on 12-Jul-2018 at 11:00 ET


Scientists Create Nano-Size Packets of Genetic Code Aimed at Brain Cancer ‘Seed’ Cells

In a “proof of concept” study, scientists at Johns Hopkins Medicine say they have successfully delivered nano-size packets of genetic code called microRNAs to treat human brain tumors implanted in mice. The contents of the super-small containers ...

– Johns Hopkins Medicine

Nano Letters; R01NS073611, R01EB016721, F31CA196163, R01CA195503


Deadly Form of Advanced Prostate Cancer Is Common, Calls for Distinct Treatment

A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer....

– UCSF Helen Diller Family Comprehensive Cancer Center

Journal of Clinical Oncology


Dermatologists, Skin Cancer Survivors Tell “Skin Cancer, Take a Hike!”

Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime. To help raise awareness of skin cancer prevention and detection, 12 dermatologists, skin cancer survivors, and their family and friends wil...

– American Academy of Dermatology


Rise of the Clones

Researchers discover new clues about a recently identified blood cell condition known as clonal hematopoiesis, implicated in hematologic cancers, cardiovascular illness Surprisingly, the study reveals that inherited genetic variants can drive the co...

– Harvard Medical School

Embargo expired on 11-Jul-2018 at 13:00 ET


Robotic Surgery as Effective as Open Surgery for Bladder Cancer

Robotic surgery is as effective as traditional open surgery in treating bladder cancer, according to a landmark study published in the journal Lancet.

– Loyola University Health System

Lancet


Why Randomized Trials for Proton Therapy Are Difficult to Complete (And What We Can Do About It)

Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating th...

– Perelman School of Medicine at the University of Pennsylvania

Journal of Clinical Oncology


Researchers Clarify Role of Mutations in Glioblastoma

Researchers investigated whether the location of the mutation within the sequence of the PIK3CA gene affected the mutation’s ability to help drive glioblastoma growth. They also tested whether mutations within certain sequences of the gene were lin...

– University of North Carolina Health Care System

PLOS ONE, July 2018


Patients with Early Kidney Cancer See Significant Benefits with Robotic Partial Nephrectomy

A comprehensive study by the Keck School of Medicine of USC has found that robotic partial nephrectomy offers significantly better patient outcomes as compared with open or laparoscopic techniques.

– Keck Medicine of USC

The Journal of Urology


International Conference Brings Together World Leaders in Eye Cancer

The world’s leading ocular oncology scientists and clinicians are meeting this summer to discuss the latest research and treatment developments in eye cancer. The Ocular Oncogenesis and Oncology Conference (OOO) will be held by the Association for ...

– Association for Research in Vision and Ophthalmology (ARVO)

The Ocular Oncogenesis and Oncology Conference, July 18- 21, 2018


Brain Metastases Common and Difficult to Treat in ROS1 Lung Cancer

Brain metastases were found to be fairly common in stage IV ROS1-positive cancers and in 47 percent of ROS1 patients, the brain was the first and only site of progression.

– University of Colorado Cancer Center

Journal of Thoracic Oncology


UC San Diego Biologists Discover Process That Neutralizes Tumors

Researchers discovered an unexpected twist in the battle versus tumors. Researchers have found that some tumor cells display not only a weapon, but also a brake, essentially becoming a neutralizing function. The unexpected mechanism could help determ...

– University of California San Diego

Cell Reports July-2018; NIH grants T32-EB009412, R00AI106941 and R21AI120010


Tip Sheet: Immunotherapy for Deadly Skin Cancer; More Money but No Better Outcome; Yoga and Music for Breast Cancer Therapy; Molecular Discoveries; Caregivers

This month's tip sheet from Fred Hutch includes story ideas about immunotherapy for a deadly type of skin cancer, cancer care that costs twice as much but yields no better outcome, yoga and music therapies for breast cancer and more. To pursue any of...

– Fred Hutchinson Cancer Research Center


Announcements


$26.5 Million Grant to Fund First Large-Scale Study on African-American Men with Prostate Cancer

The Keck School of Medicine of USC is leading a $26.5 million effort to conduct the first large-scale, multi-institutional study on African-American men with prostate cancer.

– Keck Medicine of USC


Dr. Benjamin Movsas Elected President of the Society of Chairs of Academic Radiation Oncology Programs

Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at the Henry Ford Cancer Institute, has been named President of the Society of Chairs of Academic Radiation Oncology Programs (SCAROP).

– Henry Ford Health System


$26.5M Grant Helps Investigators ‘RESPOND’ to Prostate Cancer

Rutgers Cancer Institute of New Jersey, the NJ State Cancer Registry and the NJ Department of Health are collaborating on a $26.5 million study examining African-American men and prostate cancer. The ‘RESPOND’ study is being led by the Keck Scho...

– Rutgers Cancer Institute of New Jersey


University of Chicago Medicine Comprehensive Cancer Center status renewed

Designation from the National Cancer Institute denotes the highest level of scientific excellence.

– University of Chicago Medical Center


Cedars-Sinai Affiliate Breaks Ground on New Cancer Center

Torrance Memorial Medical Center, a Cedars-Sinai affiliate, recently broke ground on the new Hunt Cancer Center. The center, a collaboration with Cedars-Sinai, will provide its patients with access to subspecialists who treat more than 60 types of co...

– Cedars-Sinai

Cedars-Sinai


Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Recognized for Quality in Value Based Cancer Care

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have been recognized with a Blue Distinction® Centers for Cancer Care designation as part of the Blue Distinction Specialty Care program.

– Rutgers Cancer Institute of New Jersey


Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers

Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) ...

– Ludwig Cancer Research


Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers

A clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) for advanced ovarian and colorectal cancers has been initiated.

– Cancer Research Institute and the Ludwig Cancer Research


$26.5 Million Grant to Fund First Large-Scale Study of African-American Men with Prostate Cancer

Johns Hopkins Kimmel Cancer Center will participate in a $26.5 million effort to conduct the first large-scale, multi-institutional study on African-American men with prostate cancer to better understand why they are at higher risk for developing mor...

– Johns Hopkins Medicine

Tips

Newswise has updated our privacy policy in order to comply with the European General Data Protection Regulation (GDPR). Please review our privacy policy statement here: https://www.newswise.com/privacy
Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 Harvard Medical School

 University of Texas M. D. Anderson Cancer Center

 Michigan Medicine - University of Michigan


Subscribe / Unsubscribe
Edit my preferences

© 2018 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us